EpiCheck is a highly innovative product for detection of cancer in liquid biopsy samples, using a panel of various methylation biomarkers
Location: Israel, Center District, Rehovot
Total raised: $137.92M
Investors 4
Date | Name | Website |
- | RA Capital... | racap.com |
- | OrbiMed | orbimed.co... |
- | Aurum Vent... | aurum.co.i... |
- | Gefen Capi... | gefencapit... |
Funding Rounds 4
Date | Series | Amount | Investors |
01.02.2022 | - | $77M | - |
26.04.2021 | - | $55M | - |
31.07.2018 | - | $2.92M | - |
25.05.2016 | - | $3M | - |
Mentions in press and media 11
Date | Title | Description | Source |
18.01.2022 | Nucleix Closes $55M Funding Round | San Diego-based Nucleix, a company revolutionizing cancer treatment by detecting the disease earlier... | sdbj.com/n... |
26.04.2021 | Nucleix Raises $55M for Early Detection of Lung Cancer | In April, Nucleix secured $55 million in funding to develop its Lung EpiCheck platform for earlier d... | sdbj.com/n... |
08.04.2021 | Liquid biopsy maker Nucleix rakes in $55M to develop blood t... | It’s full steam ahead for Nucleix’s blood test for lung cancer detection, thanks to an influx of cas... | fiercebiot... |
08.04.2021 | Liquid biopsy maker Nucleix rakes in $55M to develop blood t... | It’s full steam ahead for Nucleix’s blood test for lung cancer detection, thanks to an influx of cas... | fiercebiot... |
07.04.2021 | Nucleix has secured a $55M financing round to advance its te... | - | connect.or... |
07.04.2021 | Nucleix Nabs $55M For Lung Cancer Detection | San Diego-based Nucleix, a startup which is developing liquid biopsy technology for early detection ... | socaltech.... |
07.04.2021 | Nucleix Secures $55 Million Funding to Advance Lung EpiCheck... | - | orbimed.co... |
07.04.2021 | Nucleix Secures $55M in Funding | Nucleix, a Rehovot, Israel- and San Diego, CA-based liquid biopsy company, secured $55m in funding. ... | finsmes.co... |
31.07.2018 | Cancer Detection and Screening Startup Nucleix Receives €2.5... | Nucleix Ltd., a Rehovot, Israel-based cancer detection and screening company, received €2.5m in fund... | finsmes.co... |
25.05.2016 | Molecular Cancer Diagnostic Test Maker Nucleix Raises $3M in... | Nucleix Ltd., a Rehovot, Israel-based company that develops, manufactures and markets innovative non... | finsmes.co... |
Show more